1. Home
  2. RC vs TLSI Comparison

RC vs TLSI Comparison

Compare RC & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ready Capital Corproation

RC

Ready Capital Corproation

HOLD

Current Price

$1.36

Market Cap

272.6M

Sector

Real Estate

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$4.43

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RC
TLSI
Founded
2007
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
272.6M
270.2M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
RC
TLSI
Price
$1.36
$4.43
Analyst Decision
Hold
Strong Buy
Analyst Count
4
1
Target Price
$2.81
★ $7.00
AVG Volume (30 Days)
★ 1.0M
231.9K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
★ 2.16%
N/A
EPS Growth
★ 45.25
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $45,151,000.00
Revenue This Year
N/A
$35.45
Revenue Next Year
$67.36
$37.58
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 53.41
52 Week Low
$1.37
$2.20
52 Week High
$4.18
$7.95

Technical Indicators

Market Signals
Indicator
RC
TLSI
Relative Strength Index (RSI) 27.77 35.40
Support Level N/A $4.28
Resistance Level $1.88 $4.47
Average True Range (ATR) 0.08 0.36
MACD -0.04 -0.04
Stochastic Oscillator 1.25 2.32

Price Performance

Historical Comparison
RC
TLSI

About RC Ready Capital Corproation

Ready Capital Corp is a real estate finance company that originates, acquires, finances, and services LMM loans, SBA loans, construction loans, USDA loans and, to a lesser extent, MBS collateralized mainly by LMM loans or other real estate-related investments. Its loans are used by businesses to purchase real estate used in their operations or by investors seeking to acquire multi-family, office, retail, mixed use or warehouse properties. It operates through two segments: LMM Commercial Real Estate, which originates LMM loans across the life-cycle of an LMM property including construction, bridge, stabilized and agency loan channels, and Small Business Lending, which acquires, originates and services owner-occupied loans guaranteed by the SBA and also originates and services USDA loans.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: